-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster II

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Jatin J. Shah, MD1, Lei Feng, MS2*, Donna Weber, MD1, Sheeba K Thomas, MD1, Michael Wang, MD1, Francesco Turturro, MD1, Muzaffar H. Qazilbash, MD3, Nina Shah, MD3, Qaiser Bashir, MD3, Uday R. Popat, MD3, Elisabet E. Manasanch, MD1, Silvia C Munoz, RN1*, Ashley Landry, RN1*, Kathleen Mendoza, RN1*, Yago Nieto, MD, PhD3, Richard E. Champlin, MD3 and Robert Z. Orlowski, Ph.D., M.D.4

1Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Alex F. Herrera, MD1, Reid W. Merryman, MD2*, Katherine A. Kong, PhD3*, Heather Sun4*, Jennifer R. Brown, MD, PhD5, David C. Fisher, MD6, Matthew S. Davids, MD7, Eric D. Jacobsen, MD6, Caron A. Jacobson, MD7, Haesook T. Kim, PhD8*, Ann S. LaCasce, MD7, German A. Pihan, MD9, Aliyah R Sohani, MD10, Scott J. Rodig, M.D., Ph.D.11, Arnold S. Freedman, MD6, Jerome Ritz, MD12, Malek Faham, MD, PhD3 and Philippe Armand, MD, PhD7

1Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA
2Department of Medicine, Brigham and Women's Hospital, Boston, MA
3Adaptive Biotechnologies Corp, South San Francisco, CA
4Department of Pathology, Brigham and Women's Hospital, Boston, MA
5Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA
6Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
7Dana-Farber Cancer Institute, Boston, MA
8Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston, MA
9Pathology, BIDMC, Boston, MA
10Department of Pathology, Massachusetts General Hospital, Boston, MA
11Department of Pathology, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
12Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA

Susan Prockop, MD1, Aisha Hasan, MD1*, Ekaterina Doubrovina, MD, PhD1*, H.R. Castro-Malaspina, MD2, Juliet N. Barker, MBBS(Hons), FRACP3, Parastoo B Dahi, MD3, Farid Boulad, MD1, Nancy A. Kernan, MD1, Guenther Koehne, MD, PhD2, Craig S. Sauter, MD2, Szilard Kiss, M.D4*, Mrinali Patel, M.D.4*, Stephanie Suser, BA1* and Richard J O'Reilly, MD1*

1Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
4Department of Ophthalmology, New York Presbyterian Hospital, New York, NY

Feng Chen1*, Wu Depei, MD1, Tao Tao2*, Wei Gong2*, Chunmei Ye2*, XiaoWen Tang, MD1*, Yue Han, MD1* and Huiying Qiu1*

1Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, China
2Department of Hematology, The Loufeng Hospital of Suzhou Industrial Park, Suzhou, China

Leopold Sellner, MD1*, Peter Dreger, MD2, Max Schlitt3*, Henrik Knecht4*, Dietrich Herrmann3*, Thomas Reigl5*, Adam Krejci5*, Vojtech Bystry5*, Nikos Darzentas5*, Michael Rieger, MD1,6*, Sascha Dietrich, MD1*, Thorsten Zenz, MD1*, Anthony D. Ho, MD7, Michael Kneba3 and Monika Brueggemann3*

1Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany
2Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
3Department of Hematology, University Hospital Schleswig-Holstein, Kiel, Germany
4Hematologic Diagnostic Laboratory, University Clinic Schleswig-Holstein Campus Kiel, Kiel, Germany
5Central European Institute of Technology, Masaryk University, Brno, Czech Republic
6Oncology Practice Darmstadt, Darmstadt, Germany
7Dept. Med. V, University Hospital Heidelberg, Heidelberg, Germany

Martino Introna, MD1, Elisa Gotti, BA1*, Michela Bonzi, BA1*, Josee Golay, PhD, BA2*, Alessandra Algarotti, MD3*, Caterina Micò, MD3*, Anna Grassi, MD4*, Cristina Boschini3*, Maria Luisa Ferrari, BSc5*, Irene Cavattoni, MD6*, Ettore Biagi, MD7*, Adriana Balduzzi Sr., MD8, Attilio Rovelli, MD8*, Paolo Perseghin, MD8*, Giuseppe Gaipa, PhD9, Andrea Biondi10 and Alessandro Rambaldi, MD4

1USS Centro di Terapia Cellulare "G.Lanzani", Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
2USS Centro di Terapia Cellulare "G.Lanzani", Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
3USC Hematology, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
4Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
5Department of Hematology, Hospital Papa Giovanni XXIII, Bergamo, Italy
6Div. Hematology and TMO, Ospedale Centrale, Bolzano, Italy
7Centro Ricerca Tettamanti, Clinica Pediatrica, Università Milano Bicocca, Osp. San Gerardo/Fondazione MBBM, Monza (MB), Italy
8Hospital S.Gerardo, Monza, Italy
9Department of Pediatrics, Tettamanti Research Center, University of Milano-Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, Italy
10Pediatric Department, University Milano Bicocca, Monza, Italy

Clémence Loiseau1*, Francois Lemonnier, MD2*, Odile Randrianarivelo, MD3*, Raphael Itzykson, MD PhD4, Marie Hélène Becquemin, MD3*, Stephanie Nguyen Quoc, MD PhD2*, Madalina Uzunov, MD2*, Emilie Catherinot, MD1*, Elisabeth Rivaud, MD1*, Laurent Sutton, MD5*, Jean-Paul Vernant, MD2*, Louis Jean Couderc, MD1* and Nathalie Dhedin, MD4*

1Respiratory Disease Department, Foch Hospital, Suresnes, France
2Hematology Department, Pitie-Salpetriere Hospital, Paris, France
3Functionnal Pulmonary Test Unit, Pitie-Salpetriere Hospital, Paris, France
4Department of Hematology, Adolescents and young adults unit, Saint-Louis Hospital, Paris, France
5Hematology Department, Argenteuil Hospital, Argenteuil, France

Yosuke Tanaka, MD1*, Saiko Kurosawa, MD1*, Kinuko Tajima1*, Yoshihiro Inamoto, MD, PhD1, Reiko Ito, MD1*, Takashi Tanaka, MD1*, Yoshitaka Inoue, MD1*, Takayuki Ozawa, MD1*, Akihisa Kawajiri, MD1*, Akio Onishi, MD1*, Keiji Okinaka, MD1*, Shigeo Fuji, MD1*, Sung-Won Kim, MD1*, Ryuji Tanosaki, MD, PhD2, Takuya Yamashita, MD, PhD1 and Takahiro Fukuda, MD1*

1Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
2Department of Blood Transfusion and Cellular Therapy, National Cancer Center Hospital, Tokyo, Japan

Katarzyna Rojek, BS1, Eric Nickels1*, Barbara Niestadt1*, Rafael Marquez1*, Amittha Wickrema, PhD2, Andrew Artz, MD, MS3, Koen van Besien, MD4, Ming K Lee5*, Jeremy P. Segal, MD, PhD6*, Mary-Claire King7*, Tom Walsh5*, Akiko Shimamura, MD, PhD8, Sioban Keel, MD9, Jane E Churpek, MD1 and Lucy A Godley, MD, PhD10

1The University of Chicago, Chicago, IL
2University of Chicago, Chicago, IL
3University of Chicago Medical Center, Chicago, IL
4Division of Hematology and Medical Oncology, Weill Cornell Medical College/ New York Presbyterian Hospital, New York, NY
5The University of Washington, Seattle, WA
6Division of Genomic and Molecular Pathology, Department of Pathology, University of Chicago, Chicago, IL
7University of Washington, Seattle, WA
8Boston Children's Hospital, Boston, MA
9Medicine, University of Washington, Seattle, WA
10Section of Hematology/Oncology, University of Chicago, Chicago, IL

Keith W. Pratz, MD1, Ivana Gojo, MD1, Judith E. Karp, MD1, Leo Luznik, MD1*, B. Douglas Smith, MD1, Richard J Jones, MD2, Jackie Greer, RN1*, Christopher Gocke, MD3*, Maria R. Baer, MD4, Vu H. Duong, MD5, John J Wright, MD. Ph.D.6*, Michelle A. Rudek, PharmD, PhD1*, Ashkan Emadi, M.D., Ph.D.5 and Mark J. Levis, MD, PhD1

1Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
2Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
3Johns Hopkins, Baltimore, MD
4Greenebaum Cancer Center, University of Maryland Baltimore, Baltimore, MD
5Greenebaum Cancer Center, University of Maryland, Baltimore, MD
6CTEP, DCTD, NCI, NIH, Investigational Drug Branch, Bethesda, MD

Dolores Grosso, DNP1, Beth Colombe, PhD2*, Zi-Xuan Wang, PhD3*, Matthew Carabasi, M.D.1, Onder Alpdogan, M.D.1, Joanne E. Filicko-O'Hara, M.D.1, Margaret Kasner, M.D.1, Thomas R. Klumpp, M.D.1, Ubaldo Martinez-Outschoorn, M.D.1*, Manish Sharma, M.D.1, John L. Wagner, M.D.1, Mark Weiss, MD1 and Neal Flomenberg, M.D.1

1Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA
2Tissue Typing, Thomas Jefferson University Hospital, Philadelphia, PA
3Department of Pathology, Thomas Jefferson University Hospital, Philadelphia, PA

Michael J Eckrich, MD, MPH1, Stacy Epstein, PharmD2*, Carrie Barnhart, RN2*, Javier Oesterheld, MD3*, Darci Grochowski, PA2*, Mark Cannon, BA2* and Andrew L Gilman, MD3

1Pediatric Section of Hematology/Oncology and Transplantation, Levine Children's Hospital, Charlotte, NC
2Levine Children's Hospital- Carolinas Medical Center, Charlotte, NC
3Pediatric Blood and Marrow Transplantation, Levine Children's Hospital, Charlotte, NC

Anna Schuck, MD1*, Ariane Dienst, MD2*, Kathrin Nachtkamp, MD3*, Pia Verena Schmidt, MD2*, Esther Schuler, MD4*, Roland Fenk, MD, PhD5*, Mustafa Kondakci, MD6*, Norbert Gattermann, MD7, Rainer Haas, MD8*, Ulrich Germing, MD8*, Guido Kobbe, MD1* and Thomas Schroeder, MD8*

1Dept. of Hematology, Oncology and clinical Immunology, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany
2Dept. of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany
3Department of Haematology, Oncology and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany
4Department of Hematology, Oncology and Clinical Immunology, Universitätsklinikum Düsseldorf, Düsseldorf,, Düsseldorf, Germany
5Hematology, Heinrich Heine University, Duesseldorf, Germany
6Hematology, University Hospital Duesseldorf, Duesseldorf, Germany
7Dept. of Hematology, Oncology, and clinical Immunology, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany
8Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany

Arun Singavi, MD1, Jonathan Kapke, DO1, Adam Levin, MD1*, Anjishnu Banerjee, PhD2*, Fenlu Zhu, PhD3*, Mehdi Hamadani, MD4*, Parameswaran Hari, MD, MRCP, MS5 and Timothy S. Fenske, MD4

1Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
2Department of Biostatistics, Medical College of Wisconsin, Milwaukee, WI
3Lymphocyte Propagation Laboratory, Medical College of Wisconsin, Milwaukee, WI
4Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI
5Medical College of Wisconsin, Milwaukee, WI

Jonathan Kapke, DO1, Narendranath Epperla, MD2, Namrata Shah, MD2*, Kristin Richardson, MD3*, George Carrum, MD4, Parameswaran Hari, MD, MRCP, MS5, Mehdi Hamadani, MD2, Sai Ravi Pingali, MD6, Reem Karmali, MD, MS7 and Timothy S. Fenske, MD2

1Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
2Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI
3Department of Medicine, Rush Medical Center, Chicago, IL
4Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX
5Medical College of Wisconsin, Milwaukee, WI
6Division of Hematology & Oncology, Houston Methodist Cancer Center, Houston, TX
7Division of Hematology, Oncology and Cell Therapy, Rush University Medical Center, Chicago, IL

*signifies non-member of ASH